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Abstract. Although interventional x-ray angiography (XA) procedures involve
relatively high radiation doses that can lead to deterministic tissue reactions in addition
to stochastic effects, convenient and accurate estimation of absorbed organ doses has
traditionally been out of reach. This has mainly been due to the absence of practical
means to access dose-related data that describe the physical context of the numerous
exposures during an XA procedure. The present work provides a comprehensive
and general framework for the determination of absorbed organ dose, based on
non-proprietary access to dose-related data by utilizing widely available DICOM
radiation dose structured reports (RDSR). The framework comprises a straightforward
calculation workflow to determine the incident kerma and reconstruction of the
geometrical relation between the projected x-ray beam and the patient’s anatomy.
The latter is difficult in practice, as the position of the patient on the table top is
unknown. A novel patient-specific approach for reconstruction of the patient position
on the table is presented. The proposed approach was evaluated for 150 patients by
comparing the estimated position of the primary irradiated organs (the target organs)
with their position in clinical DICOM images. The approach is shown to locate the
target organ position with a mean (max) deviation of 1.3 (4.3), 1.8 (3.6) and 1.4 (2.9)
cm for neurovascular, adult and paediatric cardiovascular procedures, respectively.
To illustrate the utility of the framework for systematic and automated organ dose
estimation in routine clinical practice, a prototype implementation of the framework
with Monte Carlo simulations is included.
PACS numbers: 87.53.Bn, 87.57.uq, 87.59.Dj
Submitted to: Phys. Med. Biol.
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1. Introduction
Although medical imaging provides considerable improvements in the diagnosis and
treatment of a wide range of medical conditions, the radiation dose from x-ray
examinations is of concern. Some types of examinations, such as interventional x-ray
angiography (XA) procedures, involve relatively high radiation doses that can lead to
deterministic tissue reactions in addition to stochastic effects (ICRP, 2012). Over the
last decade, the individual patient’s exposure from radiological procedures has steadily
been increasing. This has primarily been due to an increased number of radiological
procedures, which in XA has been spurred by rapid advances in minimally invasive
techniques and technologies for image guidance, a trend that is likely to continue in the
future (Kagadis et al., 2012). To mitigate the risk of unnecessary radiation exposure,
and to provide data for decision support in justification and optimization, patient
radiation dose tracking is considered to be of crucial importance. The importance of
recording, reporting and tracking patients’ exposures was emphasized in a joint position
statement issued by several international organizations in 2012 (IAEA, 2012).
Even though the importance of accurate patient dosimetry is well known,
convenient, expeditious, and accurate estimation of absorbed (or equivalent) organ dose
has traditionally not been possible for XA procedures. The most accurate method
has consisted of tedious clinical measurements to determine the dose delivered to
superficial organs such as the skin, the thyroid gland and the lens of the eye (e.g.
Vano et al., 2001; Theodorakou and Horrocks, 2003). Alternative methods have been
employed based on the use of precalculated Monte Carlo (MC) factors and coefficients
(McCollough and Schueler, 2000; Schlattl et al., 2007; Benmakhlouf et al., 2011, 2013)
for the determination of absorbed dose to internal organs and to the skin. These
methods rely on dose-related data that describe the physical context of the individual
exposures of the performed XA procedure to generate an accurate dose estimate. Such
data has not been readily available in the past; consequently MC based methods have
been associated with a large uncertainty. Therefore, dosimetry of internal organs has
traditionally been limited to the estimation of effective dose using coefficients converting
cumulative (over an entire procedure) dose indices of air kerma-area product, PKA
(IAEA, 2009; NCRP, 2009). These kinds of coefficients are cumbersome to determine
and are limited to specific clinical situations (ICRU, 2006). Moreover, such coefficients
are not suitable for the estimation of absorbed organ dose, as cumulative dose indices are
poorly correlated to absorbed dose if the patient size and the specific clinical examination
technique are not taken into account (Miller et al., 2003; Karambatsakidou et al., 2005;
Compagnone et al., 2011).
A small number of applications to estimate patient skin dose (den Boer et al.,
2001; Chugh et al., 2004) have been developed based on the extraction of dose-
related data directly from specific XA systems. Unfortunately, as the developed
applications rely heavily upon proprietary access to relevant information, a widespread
clinical implementation is impeded. This issue was addressed with supplement 94 to
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the DICOM Standard, which introduced diagnostic x-ray radiation dose structured
reporting (RDSR) (DICOM, 2005) to support convenient and non-proprietary access
to dose-related data. Despite the fact that RDSR has become widely used and
also has the potential to greatly improve the accuracy of patient dose estimations
for radiological procedures, the availability of organ dose applications is scarce.
Khodadadegan et al. (2011) was the first group to develop a method for systematic
estimation of patient skin dose from XA procedures using RDSR. Shortly thereafter,
Johnson et al. (2011a) proposed a similar method for real-time skin dose mapping,
with in-clinic anthropometric measurements for patient-phantom size matching. The
described applications use methods that have been developed specifically for estimation
of patient skin dose. To our knowledge there has been no method developed for
estimation of dose to organs other than the skin.
The aim of the present work is to provide a rigorous and general framework for the
determination of absorbed organ dose in XA, based on the dose-related data contained in
RDSR. A novel patient-specific method for reconstruction of the geometrical alignment
of the patient’s anatomy with the projected x-ray beam is emphasized. Lastly, a
prototype implementation of the proposed framework combined with the MC method
is demonstrated to illustrate the utility of the framework for organ dose estimations in
routine clinical practice.
2. Methods and materials
2.1. Framework for the determination of absorbed organ dose
To estimate the absorbed dose to internal organs and to the skin from XA procedures
based on the information available in the RDSR, a comprehensive and general framework
was established as outlined in this section. The framework comprises the calculation
workflow illustrated in figure 1, which consists of three conceptually distinct parts:
• Calculation of the incident kerma in a scatter-free geometry (free-in-air).
• Reconstruction of the geometrical relation between the projected x-ray beam and
the patient’s anatomy.
• Conversion of the calculated incident kerma to absorbed organ dose, considering
both the primary component and scattering processes in the patient.
RDSR dose-related data is used for the calculation of the incident kerma, and for the
alignment of the geometry of the projected x-ray beam with a phantom model that
represents the patient anatomy, i.e. patient-phantom matching. The final step consists
in the calculation of the absorbed dose by connecting the framework to a general purpose
MC code, a particular purpose-specific MC software, or a code implementing conversion
factors. The framework provides a general approach for utilizing dose-related data
contained in RDSR for patient dosimetry, allowing any type of phantom model and
method for radiation transport in the phantom to be used in connection with it. The
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Figure 1. Illustration of the general framework for the determination of absorbed
(or equivalent) dose to internal organs and to the skin from the reference air kerma
free-in-air at the central axis of the x-ray beam. The calculation workflow is shown in
terms of the kerma free-in-air, K, and the primary (p) photon fluence differential
in energy, [ΦE ]
p. SRD and SSD is the source-to-reference and source-to-surface
distance, respectively. Also shown is the information process for utilizing RDSR in
the calculation workflow (hatched arrow).
extraction of RDSR is the topic of section 2.1.1, and the details of the framework are
presented in the subsequent sections 2.1.2 and 2.1.3.
2.1.1. Extraction of DICOM RDSR objects In accordance with IEC 60601-2-43 2nd edition
(IEC, 2010) RDSR is now required to be supported on new XA systems in order to fa-
cilitate non-proprietary access to examination data. The data contained in the RDSR is
structured as a nested set (hierarchical tree) with well defined templates. For dosimetry,
the main template is the Irradiation Event X-ray Data container (TID 10003), which
contains dose-related data for the irradiation events of a performed procedure. An ir-
radiation event is defined as a single use of radiation during a continuous length of
time as part of the examination (NEMA, 2015). Therefore, an irradiation event could
constitute a single fluoroscopy run, i.e. radioscopy, a set of stationary acquisitions, i.e.
radiography, or a single rotational acquisition, e.g. c-arm cone beam CT (CBCT) or 3D
rotational angiography (3DRA). Depending on the complexity of the XA examination,
the RDSR may contain dose-related data for hundreds of individual irradiation events.
In order to extract the data contained in the RDSR, the XA system must be
configured to transfer RDSR objects to a DICOM server where a parser (e.g. DICOM
reader) is applied. In this work, a DICOM server was installed locally using Conquest
DICOM software (Netherlands Cancer Institute, Amsterdam, the Netherlands). The
clinical XA systems at Karolinska University Hospital, Stockholm, Sweden, were
configured to automatically transfer the associated RDSR objects to the DICOM server
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(a) (b)
Figure 2. Schematic illustration of an XA system and the geometrical parameters
that describe (a) the position of the patient table top, and (b) the geometry of the
x-ray beam. The table top movement and tilting axes are shown in blue. The c-arm
movement and rotation axes about the isocenter are shown in yellow. The collimated
height and width of the x-ray beam is shown in red.
at the end of each procedure. A parser was developed using the Pixelmed Java
DICOM Toolkit (Pixelmed Publishing, Bangor, PA, USA) to extract the information
contained in the received RDSR objects, which are then sent to an open source database
(MySQL, Oracle Corporation, Redwood City, CA, USA). The database also includes
data on patient height and weight extracted from the hospital information system
(HIS). Information that can be used to identify the patient, e.g. name and personal
identification number, are anonymised to preserve healthcare information privacy.
2.1.2. Determination of the incident kerma The radiation exposure incident on the
patient surface can be modelled in its entirety by taking the physical context of each
irradiation event into account. The parameters necessary to describe the physical
context are:
(a) Geometrical parameters that describe the position of the patient table top,
illustrated in figure 2(a).
(b) Geometrical parameters that describe the size, direction and position of the x-ray
beam, illustrated in figure 2(b).
(c) Parameters that characterise the x-ray beam quality and photon fluence.
The RDSR dose-related data that can be used to describe the physical context are
summarised in table 1.
To determine the incident kerma, the fluence of the emitted x-ray beam needs to be
known for each separate irradiation event. For that purpose, the tube current-exposure
time product (mAs), which is contained in the RDSR, can be used together with x-ray
tube and beam quality specific conversion factors to account for the particular tube
output. Considering that such factors are usually not readily available, it is generally
more convenient to use the reference kerma free-in-air, Kref , which is in accordance with
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current standards included in the RDSR as the air kerma free-in-air, Kair,ref . The use of
air kerma for the determination of dosimetry quantities in diagnostic radiology is well
established and consistent with ICRU74 (ICRU, 2006) and the IAEA TRS-457 code of
practice (Alm-Carlsson et al., 2009). Note that if Kair,ref is used, it is crucial that the
accuracy of the reported value is regularly tested as part of a clinical quality assurance
program.
TheKair,ref can be transferred into incident air kerma at the patient entrance surface
as
Kair,i = Kair,refftable(SRD/SSD)
2, (1)
where the table transmission factor, ftable, accounts for the attenuation of the patient
table, SRD is the source-to-reference distance and SSD is the source-to-surface distance.
The table transmission has traditionally been determined experimentally for normally
incident x-ray beams, ignoring the greater attenuation of an obliquely incident beam.
Therefore, an analytical approach is proposed,
ftable =
∫ Emax
0
E[ΦE]
p[µen(E)/ρ]air F (E, θ, ϕ) dE∫ Emax
0
E[ΦE]p[µen(E)/ρ]air dE
, (2)
where [µen(E)/ρ]air is the photon mass energy-absorption coefficient in air for photons of
energy E, and [ΦE]
p is the primary (p) photon fluence differential in energy normalized
to unit fluence, i.e. the normalized emitted photon spectrum free-in-air. This spectrum
can be analytically calculated using a model such as Birch and Marshall (1979) or
Poludniowski (2007). Further, F (E, θ, ϕ) is the transmission of the table top and
pad calculated for monoenergetic photons incident onto the table plane at c-arm RAO
(right anterior oblique) to LAO (left anterior oblique) rotation angle, θ, and c-arm CAU
(caudal) to CRA (cranial) rotation angle, ϕ,
F (E, θ, ϕ) = exp
(
−
∑
i
[µ(E)/ρ]i(ρℓ)i
√
tan2θ + tan2ϕ+ 1
)
, (3)
where [µ(E)/ρ]i is the photon mass attenuation coefficient for material i and (ρℓ)i is the
mass thickness of material i. The mass thickness of the table and pad is not available
from the RDSR and therefore has to be considered separately. The mass thickness
can be determined in terms of carbon and water equivalent thickness from air kerma
transmission measurements for clinical emitted beam qualities, or it can be determined
based on information provided by the manufacturer.
Although the SSD in equation (1) is not available from the RDSR, it can be
approximated based on the assumption that the patient entrance surface coincides with
the surface of a phantom model whose size and shape has been matched to that of the
patient. Patient-phantom matching and how it is dealt with within the scope of the
proposed framework is the subject of the following section.
2.1.3. Patient-phantom matching In order to convert the incident kerma to absorbed
organ dose, it is imperative that the geometrical relation between the projected x-ray
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beam and the patient’s anatomy is accurately reconstructed. This is the purpose of
patient-phantom matching, for which the essential parameters are:
(a) Parameters that describe the size and shape of the patient’s body.
(b) Parameters that describe the position and orientation of the patient on the table
top.
The RDSR dose-related data that are relevant for patient-phantom matching are
summarised in table 1.
Based on the parameters that describe the size and shape of the patient’s body,
a matching phantom model can be selected. There are various models representing
patients of different ages, genders, heights and weights available (Xu, 2014), any of
which can be used within the framework. The benefits and limitations of different types
of phantom models for fluoroscopy guided interventions have been investigated elsewhere
(Johnson et al., 2011b).
With a suitable phantom model selected the next step is the geometrical alignment
of the phantom with the projected x-ray beam, i.e. reconstruction of the patient-
beam alignment. This can be achieved by matching the orientation and position of the
phantom to the patient’s position and orientation on the table top. Unfortunately, this
is not trivial, as the position of the patient is generally unknown. The few applications
that have been developed for estimation of organ (skin) dose based on RDSR data
(Khodadadegan et al., 2011; Johnson et al., 2011a) use a standard patient position. The
standard position approach (henceforth referred to as the head-centric approach, HC)
is based on the assumption that the patient’s head is placed centrally on the table
top at a predetermined distance from the head end of the table. Such an approach
relies on that the patient position is consistently reproducible and that the distance
between the patient’s head and organs away from the head, such as the target organ
(e.g. the heart for cardiovascular procedures), are correctly imitated by the phantom
model. These assumptions may introduce substantial errors in the determination of
absorbed organ dose as the dose may be calculated to other organs than the ones actually
irradiated. Hence, to improve the accuracy in dose estimations, a patient-specific
method is introduced as part of the framework: the target-centric approach (TC). The
proposed approach is based on locating the position (midpoint) of the patient’s target
organ in relation to the head end of the table, and then using that as origin for the
reconstruction of the patient-beam alignment. By using the location of the target organ
as origin instead of the head, the accuracy of the alignment is expected to be improved
for organs proximal to the target organ region, i.e. for the primarily irradiated organs.
The target-centric approach locates the target organ by taking advantage of the fact
that although various irradiation geometries are used throughout a procedure, most of
the irradiation time is dedicated to visualizing the region of the target organ. Therefore,
the position of the target organ can be estimated as the median position of the isocenter
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relative to the head end of the table,
rTCtarget =
∑
i∈{x,y,z}
median({riso(t) · ei | t ∈ X})ei, (4)
where riso(t) = (x, y, z) is the x-ray beam isocenter position relative to the head end of
the table at irradiation time t, and {ex, ey, ez} are unit vectors that form the standard
basis. The set X excludes time periods when the irradiation of the patient is presumably
not aimed at the visualization of the target region. For instance, this may for certain
types of neurovascular procedures be the exclusion of time periods when the x-ray beam
isocenter is located outside of the limitations imposed by a head fixation apparatus.
The purpose of defining such limits is to improve the accuracy in estimated target organ
position. Note that the median is used instead of the mean in the above equation for the
same reason — that is, to improve the accuracy in estimated target organ position by
excluding time periods when the irradiation geometry is not aimed at the visualization
of the target organ, i.e. by reducing the impact of the outlying riso(t). With the
target organ position located, the position of the isocenter in relation to the patient’s
anatomy at irradiation time t is reconstructed as riso(t)−r
TC
target. Details associated with
implementation of the target-centric approach using data contained in the RDSR are
given in Appendix A.
In order to evaluate the difference in accuracy of the target- and head-centric
approach, a ground truth target organ position was determined using clinical DICOM
images. The target organ was located in the DICOM images corresponding to posterior-
anterior (PA) and lateral projections (LAT) for 50 neurovascular, 50 adult and 50
paediatric cardiovascular procedures. The position of the target organ was determined
relative to the head end of the table using the isocenter position, table top head end
position, image pixel size and distance measurements provided in the DICOM header.
The position was identified as the geometrical center of the brain for neurovascular
procedures and the midpoint of the heart for cardiovascular procedures (aortic valve
used as landmark).
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Table 1. Parameters that can be used to describe the physical context of an irradiation event (a)–(c) and patient descriptors (d)–(e),
related to DICOM RDSR objects of NEMA (2015). The requirement types of the RDSR data in the scope of a vendor implementation
are: M, mandatory — shall be present; MC, mandatory conditional — shall be present if certain conditions are satisfied; U, user option
— may be present; UC, user option conditional — may be present if certain conditions are satisfied.
Parameter (Context Group ID; CID) RDSR Concept Name Type Comment
(a) Patient Table Top Position:
Position (x) (113751) Table Longitudinal Position U Along the table width direction
Position (y) (113753) Table Height Position U Along the table height direction
Position (z) (113752) Table Lateral Position U Along the table length direction
Head tilt (113754) Table Head Tilt Angle U
Cradle tilt (113756) Table Cradle Tilt Angle U
Horizontal rotation (113755) Table Horizontal Rotation Angle U
(b) X-ray Beam Geometry:
Isocenter position (x,y,z)a Not supported by DICOM RDSR
Source-to-isocenter distance (SID) (113748) Distance Source to Isocenter U
C-arm RAO–LAOb rotation (θ) (112011) Positioner Primary Angle UC
C-arm CAU–CRAc rotation (ϕ) (112012) Positioner Secondary Angle UC
Collimated beam size (113788,113789) Collimated Field Height, Width U
(c) Beam Quality and Fluence:
Kref (111636) Entrance Exposure
d at RP MC Kair,ref according to current standards
f
Source-to-reference distance (SRD) (113737) Distance Source to Reference Point U
mAs (113736) Exposuree MC Mean tube current-exposure time product
Tube kilovoltage (kV) (113733) KVP M Measured/recorded mean value or per pulse
Filter type (113772) X-Ray Filter Type U
Filter material (113757) X-Ray Filter Material U
Filter thickness (113758) X-Ray Filter Thickness Minimum U Inherent filtration not included
Table material and geometry Not supported by DICOM RDSR
(d) Patient Body Size and Shape:
Height and weight U Provided in RDSR as a patient descriptor
Sex U Provided in RDSR as a patient descriptor
Age U Provided in RDSR as a patient descriptor
(e) Patient Position and Orientation:
Position (x,y,z) Not supported by DICOM RDSR
Source-to-surface distance (SSD) Not supported by DICOM RDSR
Patient table top relationship (113745) Patient Table Relationship U E.g. headfirst or feet-first
Patient orientation (113744) Patient Orientation Modifier U E.g. prone or supine
aThe isocenter position is redundant if the table top position is defined relative to the isocenter (as was the case for the RDSR used in this work).
bX-ray image detector rotation angle from RAO (right anterior oblique) to LAO (left anterior oblique) direction with origin perpendicular to the patient’s chest.
cX-ray image detector rotation angle from CAU (caudal) to CRA (cranial) direction with origin perpendicular to the patient’s chest.
d,eNote that the term ‘Exposure’ is in the DICOM RDSR incorrectly used to refer to the physical quantity of dkerma and emAs.
fDefined as the Kair,ref at the patient entrance reference point (PERP) located on the central axis 15 cm from the isocenter towards the x-ray tube (IEC, 2010).
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2.2. Prototype implementation of the framework
To demonstrate the utility of the framework for organ dose estimation in routine
clinical practice, a prototype implementation of the framework was constructed in
MATLAB (The Mathworks Inc., Nattick, MA, USA). In order to take into account
radiation transport in the patient, the framework was connected to the commercial
MC program PCXMC (STUK, Helsinki, Finland) (Servomaa and Tapiovaara, 1998).
Although there are other more sophisticated MC codes available, they are generally
substantially slower due to more complex physics and phantom modelling. Considering
that an XA procedure may consist of hundreds of separate irradiation events and that
several thousand XA procedures a year may be performed at a large hospital, timely and
efficient dose calculations are essential. PCXMC calculates absorbed (equivalent) organ
doses and effective doses by first converting Kair,i to incident spectrum, [ΦE]
p
i , using the
spectrum model by Birch and Marshall (1979), and then simulating 2 million histories
per 10 keV photon energy bin. A script was created that automatically generates
an input file, initiates PCXMC with the command line, and extracts data from the
generated output file. The script manages each irradiation event in sequence without
the need for any user interference.
The prototype implementation of the framework is demonstrated for 50
neurovascular procedures (30 female and 20 male patients, 11–76 years old), 50 adult
cardiovascular procedures (16 female and 34 male patients, 32–95 years old), and 50
paediatric cardiovascular procedures (34 female and 16 male patients, newborn–16
years old). The procedures were performed in interventional laboratories equipped
with AlluraClarity XA systems (Philips Healthcare, Best, the Netherlands). The
neurovascular laboratory was equipped with an FD20/20 (large detector) biplanar
system, the adult cardiovascular laboratory with an FD10 (small detector) monoplanar
system, and the paediatric cardiovascular laboratory with an FD10/10 (small detector)
biplanar system.
2.2.1. Determination of the incident kerma The framework was implemented
according to section 2.1.2 to determine the incident kerma for each irradiation event
of an XA procedure. The Kair,i was calculated using equation (1), with Kair,ref and
SRD values extracted from RDSR. The SSD was approximated by analytical ray
tracing to find the distance from the x-ray source to the surface of the phantom model
whose size and shape has been scaled to emulate that of the patient (patient-phantom
matching is the subject of the following section 2.2.2). For the table transmission,
RDSR data describing the position and angulation of the projected x-ray beam were
used to determine if the x-ray beam intersects the table, and ftable was calculated using
equation (2). The [µen(E)/ρ]air and [µ(E)/ρ] values were taken from the NIST database
(Hubbell and Seltzer, 2004), and [ΦE]
p
ref was calculated by the analytical method of
Poludniowski (2007) with data generated by Poludniowski and Evans (2007) and with
RDSR data specifying the emitted beam quality. As the inherent filtration of the x-
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ray tube and tube housing is not included in the RDSR, it was taken into account
using the aluminium equivalent thickness measured with a multi-purpose detector and
a Barracuda electrometer (RTI Electronics AB, Sweden). Further, the mass thickness of
the AlluraClarity table, in terms of carbon and water, was determined from air kerma
transmission measurements carried out for clinically relevant emitted beam qualities
using an R100B dose probe attached to the Barracuda electrometer. A wide beam
geometry was used so as not to underestimate the contribution from photons forward
scattered from the patient table in the calculation of transmitted air kerma. Completely
ignoring the photons scattered from the table would bias the absorbed organ doses to
be systematically underestimated.
For rotational acquisition irradiation events, the absorbed organ dose should ideally
be determined as the sum of the absorbed dose from each individual projection x-
ray image acquired during that event. As the RDSR of the XA systems used in this
work do not provide information about individual projection images, the mean tube
kilovoltage and accumulated Kair,ref for the whole event were used to approximate the
x-ray beam quality and photon fluence. Based on the approximation that the Kair,ref
is evenly distributed amongst the different projection images, rotational irradiations
can be modelled as a set of beam projections rotated around the isocentre, with Kair,i
calculated separately for each projection. The circular trajectory of single axis rotational
irradiations were modelled as equidistantly spaced projections, 3◦ apart in rotation
angle. The curved trajectory of dual axis rotations were modelled using a template
outlining the c-arm movement, which was constructed using information available in
DICOM header tags describing the incremental change in rotation angle.
2.2.2. Patient-phantom matching PCXMC uses the slightly modified and updated
stylized hermaphrodite phantom models of Cristy and Eckerman (1987) (newborn, 1,
5, 10, 15 and 30 years old). Patient descriptors regarding the age, height and weight
of the patient were used to scale the size, mass and position of the phantom’s organs
according to ICRU (2005). It should be acknowledged that these phantoms are of
limited realism compared to modern voxelized and hybrid phantoms. However, using
these simplistic mathematical phantoms with the PCXMC software allows for highly
efficient dose simulations, which is currently a necessity for dose estimations for large
patient populations, or for routine dose calculations at a large clinic.
For accurate dose estimations, it is essential that the geometrical parameters found
in the RDSR are correctly translated to the phantom coordinate system used in PCXMC.
For that purpose the target- or the head-centric approach, described as part of the
framework (section 2.1.3), was used to match the position of the target organ or the
head of the patient to that of the phantom, respectively. For the head-centric approach,
the standard position of the patient’s head relative to the head end of the table was set
as the position that minimizes the error in target organ position compared to its ground-
truth position located in clinical DICOM images (i.e. the best-case standard position
was assumed). For the target-centric approach, the target organ was for neurovascular
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Figure 3. The upper panels show the mean source-to-surface distance (SSD)
calculated for different clinical procedures. Also shown is the source-to-reference
distance (SRD) for the frontal (N) and lateral (H) acquisition plane. The lower panels
show squared ratios of SSD to SRD, i.e. the inverse square law. The presented values
are averaged over the various irradiation events of each procedure, weighted by their
respective Kair,ref . The uncertainty bars correspond to one standard deviation.
procedures specified to be the brain, and for cardiovascular procedures to be the heart.
3. Results and discussion
3.1. Determination of the incident kerma
To determine the incident kerma, the source-to-surface distance (SSD) needs to be
determined and the attenuation of the patient table needs to be accounted for. The mean
SSD calculated for the procedures considered in this work using mathematical phantom
models whose size and shape has been matched to that of the individual patients, is
shown in the upper panel of figure 3. The values are averaged over the irradiation events
of each procedure, weighted by their respective Kair,ref . For comparison, the SRD for
each acquisition plane of the different XA systems is also shown. Although the patient
entrance reference point (PERP) is defined in such a way as to coincide approximately
with the patient entrance surface, the results indicate that it does so only for adult
cardiovascular procedures. For neurovascular and paediatric cardiovascular procedures,
the mean SSD is substantially greater than the SRD, being 71.6±3.0 and 67.6±1.1 cm,
respectively, compared to 61.3± 1.7 cm for the adult cardiovascular procedures and an
SRD of 61.5 cm for the frontal acquisition plane. Thus, approximating the geometry-
and patient-specific SSD as the SRD may overestimate the Kair,i (equation (1)) by up
to 40%, as is shown in the lower panel of figure 3.
Regarding the attenuation of the patient table top and pad, measured and
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Table 2. Air kerma transmission factors for the AlluraClarity patient table measured
for a PA projection, and calculated using equation (2) with an angle of incidence of
(θ = 0, ϕ = 0), a mass thickness of 2.5 mm carbon (2.0 g/cm3) and 0.5 mm water
(epoxy resin) for the table top, and a mass thickness of 4 mm water (PU foam) for the
pad. The measured air kerma transmission factors with and without the pad have an
estimated combined standard uncertainty of about 1% and 2%, respectively.
Inherent Added ftable ftable+pad
filtration filtration HVL1
kV (mm Al) (mm Cu) (mm Al) Measured Calculated Measured Calculated
50 3.5 0.0 2.38 0.83 0.85 0.71 0.72
80 3.5 0.0 3.75 0.86 0.87 0.76 0.76
60 4.5 0.4 5.40 0.90 0.89 0.81 0.81
70 4.5 0.9 7.74 0.91 0.90 0.84 0.83
100 4.5 0.9 10.2 0.92 0.91 0.84 0.84
calculated air kerma transmission factors for the AlluraClarity patient table are listed
in table 2, together with values calculated using equation (2). The calculated factors
are generally within the measurement uncertainty, having a maximum relative deviation
of 2.5%. As expected, the attenuation is greater for lower tube potentials and thinner
filtrations due to the relatively greater amount of low energy photons in the x-ray beam.
The results indicate that the incidentKair,i (equation (1)) may be overestimated by more
than 15% if the table top attenuation is not included in the calculations. The results
also show the importance of taking into account the combined attenuation of the table
top and pad, as that may result in an attenuation of up to 30%.
3.2. Target organ localisation
Figure 4 shows target organ positions located in DICOM images corresponding to PA
(a) and LAT (b) projections for the clinical procedures considered in this work. LAT
projections were not available for the adult cardiovascular procedures as they were
performed in an interventional laboratory equipped with a monoplanar (frontal plane)
XA system. In general, there was a wide spread in target organ position, especially in
the longitudinal direction. The one standard deviation in longitudinal direction being
3.0, 6.0 and 9.7 cm, and the range being 13.2, 27.6 and 49.1 cm for neurovascular, adult
and paediatric cardiovascular procedures, respectively. The head fixation apparatus
used for neurovascular procedures limits movement of the head in the lateral direction,
which explains the narrow spread of the midpoint of the brain in that direction.
A prerequisite for using a standard geometry to reconstruct the patient-beam
alignment (i.e. the head centric approach), is that the positioning of the patient on
the table can be consistently reproduced. This means that the observed spread in
target organ position should be mainly attributed to the variation in patient size and
not be due to a large variation in the positioning of the patient on the table. In order
to evaluate to what extent the spread in target organ position can be attributed to the
variation in patient size, the linear correlation between the target organ position and
patient age, BMI, weight and height, was analysed. Nearly all of these correlations were
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Figure 4. Target organ positions relative to the head end of the table localised
in the clinical DICOM images of 50 neurovascular (), adult (◦) and paediatric
(•) cardiovascular procedures. The target organ positions are projected onto (a)
the coronal plane and (b) the sagittal plane of the patient. The contours of the
cardiovascular table top (line) and the neurovascular table top and head fixation
apparatus (dashed line) are outlined for illustrative purposes.
absent and the rest indicated only a weak trend. This argues that the main cause for
the large spread in target organ position is the variation in the positioning of the patient
on the table top. The conclusion is also consistent with the observed clinical routine
practice for the positioning of the patient, especially for acute clinical procedures for
which time is of the essence.
3.3. Reconstruction of the patient-beam alignment
To compare the accuracy of the proposed target-centric approach with that of the
head-centric approach, the target organ positions estimated by the two methods
were compared to the position located in clinical DICOM images, i.e. the ground
truth. Recalling that the head-centric approach gives the position of the patient’s
head, the distance from the patient’s head to the midpoint of the target organ needs
to be determined to locate the target organ position using this approach. As the
actual distance is unknown, it was estimated for each patient to be the corresponding
distance in the age appropriate phantom model of Cristy and Eckerman (1987), whose
dimensions have been scaled to match the height and weight of the patient according to
ICRU (2005). Although the estimated distance in the phantom may be slightly different
for other types of phantom models, this difference is expected to be small compared to
the difference to the actual distance in the patient. Therefore, the presented results are
relevant for any type of phantom model, as they reflect the limitations associated with
the head-centric approach, more so than the limitations of the used phantom model.
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Figure 5. Distance from the target organ position located in clinical DICOM images to
the position estimated by the indicated approach for the reconstruction of the patient-
beam alignment.
As shown in figure 5, the target-centric approach was overall distinctly more
accurate and precise than the head-centric approach, locating the position of the target
organ to within 5 cm compared to 25 cm for all procedures considered in this work. Even
though the target-centric approach was notably more accurate for the neurovascular
procedures, both approaches were fairly accurate, having a mean deviation of 1.3 and
3.4 cm, and a maximum deviation of 4.3 and 7.4, respectively, for the target- and
head-centric approach. This was expected as the head was the target organ region
for the neurovascular procedures, and a head fixation apparatus was used for these
procedures to ensure suitable placement of the patients’ heads. For the adult and
paediatric cardiovascular procedures, the target-centric approach was substantially more
accurate in locating the midpoint of the heart, having a mean deviation of 1.8 and 1.4
cm compared to 6.9 and 9.7 cm, respectively. The maximum deviation was limited to
3.6 and 2.9 cm using the target-centric approach compared to 20.4 and 23.5 cm using the
head-centric approach. These results indicate that the proposed target-centric approach
can provide a major improvement over the head-centric approach for reconstruction of
the patient-beam alignment in the target organ region, i.e. the primarily irradiated
body region.
The difference in accuracy of calculated absorbed organ doses when using the target-
or head-centric approach was investigated by using the prototype implementation of the
framework to calculate the doses to the study population. The resulting doses were
compared with absorbed organ doses calculated using clinical DICOM images as the
ground truth for the reconstruction of the patient-beam alignment. The results are
presented in table 3, where the percent difference in population dose, i.e. the cumulative
dose for the study population, and the maximum absolute difference in dose to relevant
organs and effective doses are tabulated. The target-centric approach is shown to provide
considerably more accurate dose estimates compared to the head-centric approach,
having a percent difference in population dose mostly within 5%. The head-centric
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Table 3. Difference in absorbed organ (mGy) and effective (mSv; ICRP 103
(ICRP, 2007)) doses calculated for the study population (represented by the phantom
models of Cristy and Eckerman (1987)) using the target- and head-centric approach
compared to doses calculated using clinical DICOM images as the ground truth for the
reconstruction of the patient-beam alignment. Tabulated is the percent difference (PD)
in population dose and the maximum absolute difference (Max) in procedural dose.
The Max dose difference normalized by the corresponding (ground truth) absorbed
dose to the target organ is also shown in brackets (/Dtarget).
Target-centric Head-centric
PD [%] Max [mGy] (/Dtarget) PD [%] Max [mGy] (/Dtarget)
Neurovascular
Active bone marrow -1.4 0.6 (0.01) -4.8 2.3 (0.03)
Brain 3.7 12.9 (0.16) -5.8 32.3 (0.59)
Thyroid -4.4 2.7 (0.09) 7.9 13.3 (0.24)
Average dose in body -1.4 0.6 (0.01) -3.9 2.1 (0.03)
Effective dose -4.6 0.6 ( — ) -3.0 2.2 ( — )
Adult Cardiovascular
Active bone marrow 0.6 4.1 (0.06) -4.1 7.0 (0.15)
Breasts 3.8 1.2 (0.02) 25.1 6.8 (0.15)
Heart -4.6 8.0 (0.09) -34.5 41.5 (0.49)
Liver -3.8 6.7 (0.19) -35.2 16.2 (0.19)
Lungs -0.8 17.5 (0.25) -12.1 31.6 (0.45)
Oesophagus 1.7 10.8 (0.15) -17.3 31.2 (0.67)
Stomach -13.7 1.6 (0.04) 74.6 20.5 (0.29)
Average dose in body 0.0 0.4 (0.01) -2.2 1.9 (0.04)
Effective dose -1.4 1.0 ( — ) -2.1 2.7 ( — )
Paediatric Cardiovascular
Active bone marrow -3.3 0.8 (0.04) -7.4 4.3 (0.23)
Breasts (female) 14.0 10.6 (0.68) -83.0 22.8 (0.97)
Heart 2.9 2.5 (0.17) -63.7 19.0 (0.81)
Liver -3.9 3.4 (0.18) 22.1 24.5 (0.90)
Lungs -4.1 3.4 (0.18) -55.4 23.2 (1.23)
Oesophagus -1.1 3.4 (0.14) -43.1 19.4 (1.02)
Stomach 3.5 1.2 (0.06) 16.5 7.5 (0.40)
Average dose in body -2.7 1.0 (0.05) -9.4 5.5 (0.29)
Effective dose 1.2 1.1 ( — ) -33.3 8.5 ( — )
approach, on the contrary, is shown to provide a percent difference in excess of 30%
for several organs, spanning to as much as 80%. Using the target-centric approach, the
percent difference exceeds 5% only for dose to the stomach and breast tissue for adult
and paediatric cardiovascular procedures, respectively. However, it is important to note
that the dose to the stomach is generally relatively low for cardiovascular procedures,
and the maximum absolute difference is therefore limited to about 2 mGy, or about 5%
of the absorbed dose to the target organ. Also, the dose to the breast tissue for paediatric
patients is difficult to estimate considering that the volume of the tissue is small and
highly localised (less than 2.5 cm3 for phantom models corresponding to patients younger
than 15 years). Hence, even a small mismatch between the phantom model and the
patient anatomy may result in a large deviation, making any estimate of dose to breast
tissue for paediatric patients inherently associated with a large model uncertainty. The
results also suggest that the target-centric approach is markedly more robust, as the
maximum absolute difference is substantially smaller for all organs. It should be noted
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that the numerical values of table 3 are representative of the phantom models used in
this work, and are expected to be to some extent different for other types of phantom
models. However, the considerable differences in both the accuracy and precision of the
estimated absorbed organ doses demonstrated here, clearly indicate that the proposed
target-centric approach should be a major improvement over previous methods, for any
type of phantom model. This is also substantiated by the excellent agreement of the
target organ position estimated using the target-centric approach compared with its
ground truth position (shown in figure 5).
3.4. Absorbed organ dose estimation
To demonstrate the utility of the framework for organ dose estimation in routine clinical
practice, absorbed organ and effective doses were estimated for the study population
using the developed prototype implementation of the framework described in section 2.2.
The prototype simulates the radiation transport in the patient in a timely and efficient
manner; the calculation time was 10–30 minutes per XA procedure, depending on the
number of irradiation events, using two 2.3 Ghz Intel Xeon CPUs. The estimated doses
for clinical XA procedures are presented in Table 4. For neurovascular procedures, the
stationary acquisitions (radiography) contribute the most to the absorbed dose, which
is primarily due to the high image quality required to visualize the fine vasculature
of the brain. For adult cardiovascular procedures the contribution to the absorbed
dose is evenly distributed between fluoroscopy (radioscopy) and stationary acquisitions,
while the dose from rotational irradiations is minimal. For paediatric cardiovascular
procedures the majority of the contribution to the absorbed dose comes from fluoroscopy,
while the contribution from radiography is minimal, which is likely due to an effort to
avoid unnecessary high radiation exposure. The average absorbed organ dose per Kair,ref
is for paediatric patients more than five times greater than for adult patients. This is
mainly due to the x-ray beam covering a greater part of the patient body and also due
to the patients having less adipose and muscle tissue attenuating the incident beam.
Comparing the absorbed organ doses calculated in this work with those found in
the literature is difficult, as the dose depends greatly on the complexity of procedure,
irradiation geometry, system settings and patient population. Furthermore, calculation
of absorbed organ doses in such detail as presented in this work has traditionally not
been possible for XA procedures. Any comparison of absorbed organ dose would
thus inherently be biased due to the large difference in the sophistication of dose
estimation. Therefore, in order to compare the results of this work with those found
in the literature, effective doses calculated as weighted summations of absorbed organ
doses, normalized to accumulated dose indices of air kerma-area product, PKA, were used
instead. The rationale for this is that such a normalized integral dose quantity should
be less sensitive to difference in complexity of procedure and difference in sophistication
of the dose calculation introduced, for instance, by the reconstruction of the patient-
beam alignment. Table 5 shows a summary of relevant PKA to effective dose conversion
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Table 4. Mean absorbed organ doses (mGy) and effective doses (mSv; ICRP 103
(ICRP, 2007)) calculated per procedure for the study population using the target-
centric approach for the reconstruction of the patient-beam alignment. The tabulated
mean doses for the rotational acquisition irradiation events are per rotational event
instead of per procedure. The values are presented along with the standard deviation
of the mean, σ. The mean total dose normalized by the cumulative reference point air
kerma is also shown in brackets (/Kair,ref).
Stationary Rotational
Fluoroscopy acquisition acquisition Total
Mean σ Mean σ Mean σ Mean (/Kair,ref ) σ Max
Neurovascular
Active bone marrow 1.5 0.2 3.0 0.3 0.4 0.1 4.9 (0.02) 0.5 13.2
Brain 4.3 0.4 27.9 3.3 4.8 0.4 38.5 (0.18) 3.6 116.2
Thyroid 4.7 0.7 3.9 0.5 0.1 0.0 8.7 (0.04) 1.1 35.7
Effective dose 0.9 0.1 1.5 0.2 0.2 0.0 2.6 (0.01) 0.3 8.6
Adult Cardiovascular
Active bone marrow 4.3 0.6 3.7 0.4 0.5 0.1 8.1 (0.02) 0.8 25.1
Breasts 1.4 0.2 1.1 0.1 0.1 0.0 2.5 (0.01) 0.3 10.0
Heart 10.4 1.5 9.9 1.2 1.3 0.3 20.5 (0.04) 2.2 76.4
Liver 2.6 0.4 2.6 0.3 0.4 0.2 5.2 (0.01) 0.5 18.0
Lungs 9.8 1.3 9.8 1.1 1.2 0.2 19.7 (0.04) 2.0 78.0
Oesophagus 9.7 1.4 7.8 0.8 1.0 0.3 17.6 (0.04) 1.8 52.9
Stomach 1.1 0.2 1.0 0.1 0.2 0.1 2.1 (0.00) 0.2 9.9
Effective dose 3.0 0.4 2.7 0.3 0.4 0.1 5.7 (0.01) 0.5 18.7
Paediatric Cardiovascular
Active bone marrow 1.0 0.2 0.1 0.0 — — 1.2 (0.04) 0.2 6.6
Breasts 4.1 0.6 0.8 0.2 — — 5.0 (0.18) 0.7 20.9
Heart 5.1 0.8 1.0 0.2 — — 6.1 (0.22) 0.9 27.2
Liver 2.1 0.4 0.4 0.1 — — 2.5 (0.09) 0.4 16.2
Lungs 5.8 0.9 1.0 0.2 — — 6.9 (0.25) 1.0 29.3
Oesophagus 4.1 0.6 0.7 0.1 — — 4.8 (0.17) 0.7 18.4
Stomach 1.1 0.2 0.2 0.0 — — 1.3 (0.05) 0.2 6.4
Effective dose 2.0 0.3 0.3 0.1 — — 2.3 (0.08) 0.3 8.8
Table 5. Mean PKA to effective dose conversion coefficients (CE) in units of
mSv/mGycm2
Procedure Reference CE
Neurovascular Manninen et al. (2012) 0.06–0.07
NCRP (2009) 0.09
This work 0.08
Adult Cardiovascular Compagnone et al. (2011) 0.11–0.20
IAEA (2009) 0.18
NCRP (2009) 0.12–0.28
This work 0.22
Paediatric Cardiovascular Karambatsakidou et al. (2009) (3.7, 1.9, 1.0, 0.6, 0.4)a
This work (3.2, 2.2, 1.3, 0.8, 0.4)a
aCorresponds to ages (0–0.5, 0.5–2.5, 2.5–7.5, 7.5–12.5, 12.5–18) years.
coefficients found in the literature and the corresponding mean value calculated in
this work for a general neurovascular, adult and paediatric cardiovascular procedure.
Overall, the results of this work are in good agreement with other publications.
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4. Conclusions
A comprehensive framework for absorbed organ dose calculation in XA based on the
dose-related data contained in RDSR has been presented. The framework provides
a general approach, allowing any type of phantom model and method for radiation
transport in the phantom to be used to estimate the absorbed dose to internal organs
and to the skin. Furthermore, a novel method for reconstruction of the geometrical
alignment of the patient’s anatomy with the projected x-ray beam has been proposed
and validated. The main advantages of the new approach are that it is patient- and
procedure-specific and requires no user input or additional handling of the patient, such
as clinical measurements or application of fiducial markers. This approach has been
shown to be a major improvement over previous methods for reconstruction of the
patient-beam alignment in the target organ region, i.e. the primarily irradiated body
region and therefore the region of main concern.
The present work has demonstrated the means for systematic and fully automated
calculation of absorbed organ doses on a patient-specific basis for XA procedures in
routine clinical practice, something that has traditionally not been possible. Such
calculations can be used to better understand the patient radiation exposure, which
is invaluable for optimization of clinical methods and protocols. They further allow
cumulative dose recording for individual patients, which will provide valuable data for
epidemiological studies on the long-term harmful effects of low dose ionizing radiation.
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Appendix A. The target-centric approach for reconstruction of the
patient-beam alignment
The proposed algorithm for estimating the target organ position, rTCtarget, is summarized in
pseudocode in algorithm Appendix A.1, with the input RDSR data defined in table A1.
In order to obtain rTCtarget, the algorithm constructs the x-ray beam isocenter position
relative to the head end of the table as a function of irradiation time, riso(t) = (x, y, z),
and then solves equation (4) for t ∈ X . Given that the x-ray beam isocenter position
(rb) and the table head end position (rt) are expressed in terms of the same coordinate
system, then riso can for irradiation event i be defined as riso,i = rb,i−rt,i. riso(t) can thus
be formulated as a step function defined as a linear combination of indicator functions,
riso(t) =
∑
i
riso,i1Ti(t), (A.1)
where 1T (t) is the indicator function of a subset T of irradiation times,
1T (t) =
{
1 if t ∈ T
0 if t /∈ T
. (A.2)
To improve the accuracy in estimated target organ position, the algorithm
determines the set X of irradiation times when the following constraints are considered.
For neurovascular procedures only irradiation geometries corresponding to a target
position within a lateral distance of d (25 cm in this work) from the table top
head end are considered, i.e. |z(t)| ≤ d. Also, since in some cases a substantial
amount of fluoroscopy image guidance is carried out distal from the target region,
only stationary acquisition irradiation events are considered, the exception being if no
stationary acquisition irradiation events have been performed, in which case all events
are considered.
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Table A1. Definition of the input RDSR data for algorithm Appendix A.1.
Notation Type Description
rb array of vectors for n irradiation events x-ray beam isocenter position
a
rt array of vectors for n irradiation events table top head end position
a
w array for n irradiation events irradiation duration
A array for n irradiation events irradiation event type
s string study description
a(x, y, z) = (Along the table width direction, height direction, length direction).
Algorithm Appendix A.1.
Input: n-array rb, rt, w and A, string s
let riso,i = rb,i − rt,i, w0 = 0
if ∃i : Ai = {stationary acquisition} then
let X = ∅ else let X = {t | w0 < t ≤
n∑
i=1
wi}
end
for i = 1 to n do
let Ti 7 →{t | wi−1 < t ≤ wi−1 + wi}
if Ai = {stationary acquisition} then
let X 7 →X ∪ Ti
end
if s = {neurovascular} and |zi| > d then
let X 7 →X \ Ti
end
end
solve equation (4) with riso(t) =
n∑
i=1
riso,i1Ti(t), given X .
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